PMA's concerns about therapeutic substitutions.
Allnutt
R F
RF
Pharmaceutical Manufacturers Association, Washington, D.C.
D000319:Adrenergic beta-Antagonists / Q000493:pharmacokinetics*; D006801:Humans; D007258:Informed Consent; D008484:Medicaid / Q000191:economics; D010594:Pharmacies / Q000191:economics*; D011306:Prescription Fees; D013810:Therapeutic Equivalency; D014481:United States
D000319:Adrenergic beta-Antagonists